Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05462613
Title Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer (REPROGRAM-02)
Acronym REPROGRAM-02
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de Besançon RECRUITING Besançon France Details
Hôpital Henri Mondor RECRUITING Créteil France Details
Centre Georges François Leclerc RECRUITING Dijon France Details
Centre Léon Bérard NOT_YET_RECRUITING Lyon 69000 France Details
Hôpital Privé Jean Mermoz RECRUITING Lyon France Details
Hôpital Nord Franche Comté RECRUITING Montbeliard France Details
Groupe hospitalier de la région de Mulhouse et Sud Alsace RECRUITING Mulhouse France Details
Hôpital Européen Georges Pompidou RECRUITING Paris France Details
Hôpital la Pitié-Salpétrière NOT_YET_RECRUITING Paris France Details
Hôpital Saint antoine RECRUITING Paris France Details
Institut Mutualiste Montsouris RECRUITING Paris France Details
CHU de Reims - Hôpital Robert Debré NOT_YET_RECRUITING Reims France Details
Hôpital FOCH NOT_YET_RECRUITING Suresnes France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field